PATENT CLAIM ANALYSIS

Application Number: 15901361
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-11
Patent Classification: ["514", "309000"]

Abstract:
Described herein are compounds and compositions for treating glaucoma and/or reducing intraocular pressure. Compositions may comprise an isoquinoline compound and a prostaglandin or prostaglandin analog. Compounds described herein include those in which an isoquinoline compound is covalently linked to a prostaglandin or a prostaglandin analog, and those in which an isoquinoline compound and a prostaglandin free acid together form a salt.

Claim (Index 29):
The compound of claim  1 , wherein R 10  is:\n aryl substituted with \u2014CH 2 \u2014OC(O)\u2014R a , wherein R a  is 2,4-dimethylphenyl; 4-chlorophenyl; or aryl substituted with \u2014CH 2 \u2014OC(O)\u2014NH\u2014R b , wherein R b  is phenyl, 2-chlorophenyl, 4-chlorophenyl, 4-methoxyphenyl, or C 1-4  alkyl.

Metadata:
- Claim Count in Document: 35.0
- Percentile: 88.0
- Lexical Diversity: 1.625
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14213961', '15236625', '15627238', '15142461', '11728897']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7940934584919991
- 35 USC 102 Novelty (BERT): 0.5347327203726328
- Combined Prediction Score: 0.7681573846800624
- Mean Citation Score: 332.56603399999995
- Max Citation Score: 367.16824
- Similarity Product: 254.8430141088343

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test